Once-weekly navepegritide improved growth velocity, skeletal alignment, and functional outcomes in children with achondroplasia, with a favorable safety profile and potential implications for long-term care.
Carlos A. Bacino, MD
Advertisement
Carlos A. Bacino, MD, Baylor College of Medicine, Houston, Texas.
Articles by Carlos A. Bacino, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Special Report: Type 1 diabetes and the concept of remission
2
Phase 3 trial meets primary end point for Viaskin peanut patch in children aged 4 to 7 years
3
Climate change lag time and pediatric health: Why we should care about this urgent need
4
Mimi C. Lee, MD, PhD, breaks down GeneDx's ExomeDx and GenomeDx tests
5